Skip to content
★ Sign in to follow
PB

Pharmaron Beijing Co., Ltd. - H Shares Stock: price and insider trades · Hong Kong

Pharmaron Beijing Co., Ltd. - H Shares: what insiders have been doing

Every trade that managers of Pharmaron Beijing Co., Ltd. - H Shares disclose to HKEX is tracked on this page. Between 8 November 2025 and 8 November 2026, 3 insiders published 9 filings.

Only sales appear on the open market, 6 sales in all totalling €88.1M, filed by 3 insiders. The totals do not cover 4 filings with an undisclosed amount. The largest single trade was a sale of €81.2M by Lou Boliang, published on 16 October 2026.

For context, the typical company on the same exchange (median of 750 companies) published 5 filings over the same period, against 9 filings here. Looking back to 2026, when coverage begins, insiders filed no purchases and 6 sales.

Typically, a trade is published a median of 3 days after it takes place. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.

Source: insider filings from HKEX. Past trades are no guide to future returns.

Insider Decl.
9
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€88M
6 ops. · all time

Who traded when

BuySale
Lou Boliang2 sales
Lou Xiaoqiang2 sales
Zheng Bei2 sales

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

· cache

Last declaration on 16 October 2026
Declarations9 total
  • ▼
    DirectorExecutives
    715M HKD0HKEX
    18,373,000 shares@ HK$38.89ShareXHKGHKEX:DA20261016E00495
  • ▼
    DirectorExecutives
    0HKEX
    18,373,000 sharesShareXHKGHKEX:DA20261016E00501
  • ▼
    DirectorExecutives
    0HKEX
    18,373,000 sharesShareXHKGHKEX:DA20261016E00496
  • ●
    DirectorExecutives
    0HKEX
    6,000,000 sharesShareXHKGHKEX:DA20260821E00468
  • ▼
    DirectorExecutives
    0HKEX
    1,329,000 sharesShareXHKGHKEX:DA20260821E00487
  • ▼
    DirectorExecutives
    0HKEX
    1,329,000 sharesShareXHKGHKEX:DA20260821E00469
  • ▼
    DirectorExecutives
    64M HKD31HKEX
    1,329,000 shares@ HK$47.95450.11% mcap100.0% of flowShareXHKGHKEX:DA20260821E00486
  • ●
    DirectorExecutives
    0HKEX
    350,000 sharesShareXHKGHKEX:DA20260803E00011
  • ●
    DirectorExecutives
    0HKEX
    4,000,000 sharesShareXHKGHKEX:DA20260610E00352

9 of 9 declarations

About Pharmaron Beijing Co., Ltd. - H Shares

Pharmaron Beijing Co., Ltd. is a Chinese company specializing in research and development services for the pharmaceutical industry. It offers integrated solutions ranging from drug discovery to manufacturing.